NewsRadar
Home
Research
Products & Services
Online Data Service
Deals in Europe Report
Radar
Advanced Search
Add Company
Add Person
Customized Research
Weekly Newsletter
Online News
Events

Diatos SA
Biopharmaceutical company focused on the development of novel cancer treatments using its core technologies for tumor selective targeting and intracellular drug delivery.

Diatos is a spin-off from the from Institut Pasteur.


• Show past press releases
• Edit this company

CONTACT INFORMATION
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
166, boulevard du Montparnasse
Paris 75014
France
+33 (0)1 5380 9340
+33 (0)1 5380 9389
http://www.diatos.com
John Tchelingerian
+33 (0)1 5380 9381

COMPANY FACTS
Founded:Feb 1999
Founders:Institut Pasteur, Sofinnova Partners
CEO:Dr John Tchelingerian
CTO or technical lead:Denis Ravel
CFO or finance director:Christophe Bourrilly
Head of Sales:James Cowburn
Head of Marketing:James Cowburn

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:40
Profitability:Pre-revenue
Funding raised:Yes
Funding sought:No
Seeking Partnerships:Yes

NON-EXECUTIVE BOARD MEMBERS

KEY CUSTOMERS

KEY BUSINESS PARTNERS

KEY COMPETITORS

CAPITAL RAISED
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

PUBLIC OFFERINGS
DateTypeExchange
No public offerings




Copyright © 1999-2010
Test Publishing Limited. All rights reserved. Legal Information.